Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
J Clin Endocrinol Metab. 2020 Jun 1;105(6). doi: 10.1210/clinem/dgz225.
Genetic factors are major determinants of thyroid function. Over the last two decades, multiple genetic variants have been associated with variations in normal range thyroid function tests. Most recently, a large-scale genome-wide association study (GWAS) doubled the number of known variants associated with normal range thyrotropin (TSH) and free thyroxine (FT4) levels.
This review summarizes the results of genetic association studies on normal range thyroid function and explores how these genetic variants can be used in future studies to improve our understanding of thyroid hormone regulation and disease.
Serum TSH and FT4 levels are determined by multiple genetic variants on virtually all levels of the hypothalamus-pituitary-thyroid (HPT) axis. Functional follow-up studies on top of GWAS hits has the potential to discover new key players in thyroid hormone regulation, as exemplified by the identification of the thyroid hormone transporter SLC17A4 and the metabolizing enzyme AADAT. Translational studies may use these genetic variants to investigate causal associations between thyroid function and various outcomes in Mendelian Randomization (MR) studies, to identify individuals with an increased risk of thyroid dysfunction, and to predict the individual HPT axis setpoint.
Recent genetic studies have greatly improved our understanding of the genetic basis of thyroid function, and have revealed novel pathways involved in its regulation. In addition, these findings have paved the way for various lines of research that can improve our understanding of thyroid hormone regulation and thyroid diseases, as well as the potential use of these markers in future clinical practice.
遗传因素是甲状腺功能的主要决定因素。在过去的二十年中,多种遗传变异与正常范围内甲状腺功能检测的变化相关。最近,一项大规模全基因组关联研究(GWAS)将与正常范围促甲状腺激素(TSH)和游离甲状腺素(FT4)水平相关的已知变异数量增加了一倍。
本综述总结了正常范围内甲状腺功能的遗传关联研究结果,并探讨了这些遗传变异如何在未来的研究中用于提高我们对甲状腺激素调节和疾病的理解。
血清 TSH 和 FT4 水平由下丘脑-垂体-甲状腺(HPT)轴的多个遗传变异决定,几乎在所有水平上。GWAS 之后的功能后续研究有可能发现甲状腺激素调节的新关键因素,例如甲状腺激素转运蛋白 SLC17A4 和代谢酶 AADAT 的鉴定。转化研究可以利用这些遗传变异在孟德尔随机化(MR)研究中研究甲状腺功能与各种结果之间的因果关系,以识别甲状腺功能障碍风险增加的个体,并预测个体 HPT 轴基准。
最近的遗传研究极大地提高了我们对甲状腺功能遗传基础的理解,并揭示了其调节中涉及的新途径。此外,这些发现为各种研究铺平了道路,可以提高我们对甲状腺激素调节和甲状腺疾病的理解,以及这些标记物在未来临床实践中的潜在用途。